Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
University of Cape Town · South African Tuberculosis Vaccine Initiative · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,039
total citations
- FWCI
- 62.99
- Percentile
- 100%
- References
- 40
Citations per year
Authors
12- MTMichèle TamerisCorresponding
University of Cape Town, South African Tuberculosis Vaccine Initiative
- MHMark Hatherill
University of Cape Town, South African Tuberculosis Vaccine Initiative
- BLBernard Landry
Aeras
- TJThomas J. Scriba
University of Cape Town, South African Tuberculosis Vaccine Initiative
- MAMargaret Ann Snowden
Aeras
Topics & keywords
Topics
Keywords
- Medicine
- Tuberculosis
- Vaccination
- Adverse effect
- Tuberculosis vaccines
- Placebo
- BCG vaccine
- Clinical endpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.